These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11273125)

  • 1. Unsuspected filariasis coexisting with leishmaniasis in a splenic aspirate.
    Jain S; Rani S; Jain SK
    J Assoc Physicians India; 1998 Feb; 46(2):238-9. PubMed ID: 11273125
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
    Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
    J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
    Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
    Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-emergence of visceral leishmaniasis in Gujarat, India.
    Sharma U; Redhu NS; Mathur P; Singh S
    J Vector Borne Dis; 2007 Sep; 44(3):230-2. PubMed ID: 17896628
    [No Abstract]   [Full Text] [Related]  

  • 6. Visceral leishmaniasis in a non-endemic area of India.
    Sud A; Varma N; Marwaha RK; Patel FM; Trehan A; Singh S; Varma S
    Trop Doct; 2004 Oct; 34(4):247-9. PubMed ID: 15510962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
    J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune haemolytic anaemia due to visceral leishmaniasis in a young child.
    Boel M
    Eur J Pediatr; 2003 Jun; 162(6):444; author reply 445. PubMed ID: 12712333
    [No Abstract]   [Full Text] [Related]  

  • 11. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 13. Visceral leishmaniasis associated hemophagocytic syndrome in patients with chronic granulomatous disease.
    Martín A; Marques L; Soler-Palacín P; Caragol I; Hernandez M; Figueras C; Español T
    Pediatr Infect Dis J; 2009 Aug; 28(8):753-4. PubMed ID: 19633526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine.
    Avasthi R; Chaudhary SC; Khanna S
    Indian J Med Microbiol; 2009; 27(1):85-6. PubMed ID: 19172077
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leishmaniasis in a splenectomized thalassodrepanocytic young adult].
    Pavone P; Giugno GR; Luca G; Samperi P; Consalvo C; Lucenti C
    Minerva Pediatr; 2005 Oct; 57(5):325-8. PubMed ID: 16205619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.
    Jha TK; Sundar S; Thakur CP; Felton JM; Sabin AJ; Horton J
    Am J Trop Med Hyg; 2005 Dec; 73(6):1005-11. PubMed ID: 16354802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral leishmaniasis--surgical aspects].
    Oniţa M; Hornung E; Ciobanu C; Sârbu AE; Olariu T; Oniţa C; Stoica AL
    Chirurgia (Bucur); 2006; 101(3):335-9. PubMed ID: 16927925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis in a patient with Wegener's granulomatosis.
    Sollima S; Corbellino M; Piolini R; Calattini S; Imparato S; Antinori S
    Rheumatology (Oxford); 2004 Jul; 43(7):935-7. PubMed ID: 15213342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.